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Microsporidiosis is a fungal infection that generally causes 
digestive disorders, especially in immunocompromised 
hosts. Over a 4-day period in January 2018, 3 patients with 
hematologic malignancies who were admitted to the hema-
tology unit of a hospital in France received diagnoses of En-
terocytozoon bieneusi microsporidiosis. This unusually high 
incidence was investigated by sequence analysis at the in-
ternal transcribed spacer rDNA locus and then by 3 micro-
satellites and 1 minisatellite for multilocus genotyping. The 
3 isolates had many sequence similarities and belonged to 
a new genotype closely related to genotype C. In addition, 
multilocus genotyping showed high genetic distances with 
all the other strains collected from epidemiologically unre-
lated persons; none of these strains belonged to the new 
genotype. These data confirm the epidemiologic link among 
the 3 patients and support a common source of infection.
Microsporidia are spore-forming eukaryotic and oppor-tunistic intracellular pathogens related to fungi (1,2). 
Microsporidiosis usually occurs in the form of isolated 
cases in immunocompromised patients, including HIV-in-
fected persons and solid-organ transplant recipients (1) but 
can also arise in travelers and is common in children in de-
veloping countries. Infection causes digestive disorders, in-
cluding diarrhea (1,3). Microsporidia are orally transmitted 
by interindividual contacts and likely less frequently trans-
mitted by foodborne or waterborne spores from excreta of a 
wide range of host species (1,4). At least 16 microsporidian 
species have been described in humans, but Enterocytozoon 
bieneusi is the most common (5). However, little is known 
about the actual epidemiology of E. bieneusi microsporidi-
osis, and there is a need for a better understanding of its 
pathophysiology and parasitic cycle (3,5). Unfortunately, 
epidemiologic studies are complicated because E. bieneusi 
infection has a low incidence rate worldwide (6), and its 
microbiological diagnosis is difficult and likely often over-
looked (7). In addition, the species is not easy to cultivate 
in vitro in routine practice. Investigations can be carried out 
directly only from infected biologic samples, which usually 
use DNA from fecal specimens (1,3,7).
More than 250 genotypes of E. bieneusi have been 
identified on the basis of their internal transcribed spacer 
(ITS) region (8,9). Depending on the ITS genotypes, zoo-
notic or host-adapted groups have been identified within 
species. Phylogenetic studies were able to distinguish >10 
groups; most ITS genotypes belonged to group 1, which 
contains genotypes found in both humans and animals, in-
cluding cats, pigs, and cattle (2). However, ITS sequencing 
has certain limitations because the same ITS genotype can 
be isolated from different host species and from different 
regions. This possible strain diversity within 1 ITS geno-
type cannot be addressed by a single sequence-based geno-
typing technique (10).
In human and animal medicine, several molecular 
techniques have been developed to investigate the epidemi-
ology of transmissible agents (11–15), such as multilocus 
sequence typing (MLST) analysis or mini/microsatellite 
length polymorphism using short tandem-repeat markers. 
A MLST method was developed in 2011 to discriminate 
among E. bieneusi isolates (16). Four loci were analyzed 
with 1 minisatellite (MS4) and 3 microsatellites (MS1, 
MS3, and MS7). The combination of these 4 markers with 
the ITS genotype allows for the determination of multilocus 
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genotypes (MLGs). MLG analyses are useful to discrimi-
nate between isolates derived from various hosts (17) and 
to detect mixed infections (18).
To assess epidemiologic links among 3 cases of E. bi-
eneusi infections occurring concomitantly in a single he-
matology unit in a hospital in France, we used the MLG 
analysis method. The results showed the utility of this ap-
proach in the investigation of a cluster of cases.
Materials and Methods
Ethics
The study patients gave informed consent for the use of 
their samples in the research project. All their personal data 
were anonymous. We received approval from the ethics 
committee of the University Hospital of Tours (Center 1, 
Espace de Réflexion Éthique, Région Centre-Val de Loire, 
France). The study registration number 2015_003 was is-
sued by the National Commission for Information Tech-
nology and Individual Freedom (Commission Nationale de 
l’Informatique et des Libertés) on January 10, 2015. We 
performed the study in accordance with the Code of Ethics 
of the World Medical Association (Declaration of Helsin-
ki) and complied with BRISQ guidelines (19). We received 
technical and financial support from the French Microspo-
ridiosis Network, assisted by the Clinical Research and In-
novation Department (DRCI) of the University Hospital 
of Clermont-Ferrand (Center 2) and the French National 
Reference Center for Cryptosporidiosis.
Context of the Study
Center 1 is a university hospital in France that contains 
2,008 inpatient beds and comprises 3 main sites spread 
over a distance of a few kilometers. The hematology unit 
is located in the Center for Adult Medicine (Tours, France; 
latitude 47.3900474, longitude 0.6889268). Systematic sur-
veillance and exhaustive registration of all cases of micro-
sporidiosis began in the hospital in January 2011. During 
January 2011–January 2018, there were 33,769 inpatient 
admissions. Only 2 cases of E. bieneusi were diagnosed in 
the hematology unit and the oncology department in pa-
tients admitted in 2017; these cases occurred at different 
times. In contrast, 3 patients with hematologic malignan-
cies, designated M01-05 to M01-07, received diagnoses of 
E. bieneusi microsporidiosis during a 4-day period, January 
12–16, 2018.
Biologic Procedures for Routine Diagnosis  
of E. bieneusi Infection
All diarrheic fecal specimens and feces obtained from 
high-risk patients, including HIV-positive persons, solid-
organ/bone-marrow transplant recipients, and patients with 
cancer or autoimmune diseases (1,20), were systematically 
screened for microsporidia in the parasitology–mycology 
laboratory of center 1. The first-line diagnostic procedure 
used a real-time qualitative PCR (qPCR) that targets the 
18S rRNA gene of E. bieneusi. We performed genomic 
DNA extraction with the QIAmp DNA Stool Mini Kit 
(QIAGEN, https://www.qiagen.com), according to the 
manufacturer’s instructions. We stored DNA extracts at 
–20°C until subsequent analysis. We completed amplifica-
tion with Eb and Eb5 oligonucleotide primers at a final con-
centration of 0.5 µmol/L and detected the 180-bp product 
using the specific fluorescent TaqMan probe EbS2 in the 
LightCycler 480 II apparatus (Roche, https://www.roche.
com) as described previously (7,21). We set the positive 
cutoff value of qPCR at <39 quantitative cycles (Cq) and 
tested each clinical sample in duplicate. We assessed in-
hibition with a positive exogenous internal control (Uni-
versal Inhibition Control Cy5; Diagenode, https://www.
diagenode.com). We confirmed all samples with positive 
qPCR results using microscopy with specific staining of 
microsporidia spores by the Uvitex 2B brightener (Ciba-
Geigy, https://www.novartis.com) according to van Gool’s 
method (22) (Appendix Figure 1, http://wwwnc.cdc.gov/
EID/article/25/9/19-0311-App1.pdf). 
Study Population and Biologic Samples
In this study, we included all patients from center 1 who 
were found to be positive for E. bieneusi detection dur-
ing January 2011–December 2018; they were considered 
a priori to be epidemiologically unrelated to the 3 cluster 
cases (M01-05 to M01-07). We included 8 supplementary 
control cases in the study: 4 were provided by a second uni-
versity hospital, center 2 (Clermont-Ferrand, France; lati-
tude 45.759549, longitude 3.089723), and the remaining 
4 by another university hospital, center 3 (Nantes, France; 
latitude 47.2121974, longitude –1.554346).
Genotyping of Clinical E. bieneusi Strains
Genotype Identification by Sequence Typing  
of ITS rDNA Region
We amplified the DNA extract in a 25-µL final volume 
and sequenced it for the ITS rDNA region. For patients 
with multiple positive samples, we tested only the first 
sample by genotyping. We used the MSP3 and MSP4B 
primers (23). ITS PCR products were purified and nucle-
otide sequencing performed on both strands by Eurofins 
Laboratories (https://www.eurofins.com). We compared 
the 243-bp sequences obtained with all E. bieneusi se-
quences available from the National Center for Biotech-
nology Information using the BLAST algorithm (http://
blast.ncbi.nlm.nih.gov/Blast.cgi). We performed the 
evolutionary analysis of E. bieneusi ITS genotypes with 
MEGA version 7.0.26 (https://www.megasoftware.net) 
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(24) and aligned all genotypes with 40 E. bieneusi ITS 
genotype sequences from GenBank(9).
Minisatellite and Microsatellite Polymorphism Genotyping
We studied the genetic diversity of the clinical strains of 
Enterocytozoon bieneusi further by analyzing 1 minisatel-
lite (MS4) and 3 microsatellites (MS1, MS3, and MS7), 
as previously described (16). We defined sequence types 
by comparing MS sequences. We then performed mul-
tilocus analysis by combining ITS sequences with the 4 
MS markers to define MLGs. We used the Clustal Omega 
algorithm (https://www.ebi.ac.uk/Tools/msa/clustalo) for 
sequence alignment and examined the relationship be-
tween MLGs by a median-joining network analysis using 
Network version 5.0.1.1 and Network Publisher version 
2.1.1.2 software (http://www.fluxus-engineering.com). 
To confirm the clustering of cases, we also performed an 
evolutionary analysis of combined nucleotide sequences 
by the maximum likelihood method based on the Tamura 
3-parameter model in MEGA version 7.0.26. We upload-
ed all sequences to GenBank (accession numbers in Ap-
pendix Table).
Transmission Map
We studied patient movements within center 1 and to iden-
tify possible sites where the 3 cluster cases with E. bieneusi 
microsporidiosis (M01-05 to M01-07) may have come 
into contact. To do so, we extracted dates of outpatient 
visits and hospitalizations retrospectively from the medi-
cal records (Dossier Patient Partagé, Cerner SAS, Paris-La 
Défense, France).
Results
Description of Cluster Cases
During January 1–December 31, 2018, we found 44 fecal 
samples obtained from 25 patients at center 1 positive for 
E. bieneusi (overall prevalence 0.53% of fecal samples; 
Figure 1; Appendix Figure 1). The cohort of microsporidio-
sis cases included HIV-infected persons; solid-organ trans-
plant recipients; and patients with hematologic malignan-
cies, autoimmune diseases, or cirrhosis (Appendix Table). 
The yearly frequency of diagnosis of E. bieneusi infection 
varied randomly during the study period (Figure 1). The 3 
cluster cases of E. bieneusi microsporidiosis (M01-05 to 
M01-07) were diagnosed in the same hematology depart-
ment over a 4-day period, January 12–16, 2018. All 3 pa-
tients had been admitted to the hospital for symptoms of di-
arrhea, deterioration of their general health status, or both. 
No individual risk behaviors, including swimming in wild 
rivers, consumption of nonpotable water, or close contact 
with animals, were identified in these patients. They resid-
ed in towns that were geographically located at distances 
28.7–104.0 km apart. 
Full details of all their medical consultations and hos-
pital admissions were available and in-hospital movements 
collected (Figure 2). Only 1 period for possible direct pa-
tient-to-patient contact was determined: December 26–28, 
2017, in the hematology inpatient department. The patients 
were placed in neighboring rooms 15 and 17 days before 
the first sample was found positive for E. bieneusi, the only 
period of concomitant hospitalization. However, during 
January 11–12, 2018, patients M01-06 and M01-07 spent 
time in 3 different but closely located hospital wards: in 
the short-stay oncology unit (M01-06) and in the hematol-
ogy inpatient department and the oncology outpatient unit 
(M01-07). These 3 clinical units are in the same hospital 
building on the same floor and share the same food and 
water supplies and some common healthcare staff.
ITS Genotyping of Clinical E. bieneusi Strains
We included 33 cases in our study; 25 from center 1, 4 from 
center 2, and 4 from center 3 were successfully genotyped. 
The remaining 8 cases were unavailable for genotyping 
(Figure 1). On the basis of ITS rDNA sequencing, we de-
termined that the 3 E. bieneusi strains from cluster cases 
belonged to a new genotype, closely related to genotype C 
(referred to hereafter as C-like01; Appendix Figure 2). We 
identified 2 other new genotypes in the center 1 cohort: C-
like04, which was closely related to genotype C (synonym 
genotype II), and IV-like01, closely related to genotype IV 
(synonym genotype K) (Appendix Figure 2). C-like01 and 
C-like04 genotypes differed from genotype C by 1 single-
nucleotide polymorphism (SNP), at positions 83 (G→A) 
for the C-like01 genotype and 236 (G→A) for the C-like04 
genotype. The IV-like01 genotype also differed from the 
IV genotype by 1 SNP (G→A) at position 236 (Appen-
dix Figure 3). Other genotypes identified in our study 
Figure 1. Incident number and 
ITS rDNA region genotypes of 
Enterocytozoon bieneusi infection 
cases (n = 25) in center 1 university 
hospital, France, January 1, 2011–
December 31, 2018. ITS, internal 
transcribed spacer.
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(Appendix Table) belonged to genotypes C (n = 13), IV (n 
= 3), and S9 (n = 2).
MLG Analyses 
We performed MLG analyses using the combination of 
ITS with MS1, MS3, MS4, and MS7 loci. In 3 of the 25 
isolates (M01-18, M01-77, and M01-79), >1 MS mark-
ers could not be successfully amplified (Appendix Table). 
Amplification efficiency was 96.0% for MS1, 92.0% for 
MS3 and MS7, and 88.0% for MS4. Sequence analysis of 
each MS marker showed a high diversity of sequence types 
(STs). The MS3 marker was the least variable marker, with 
only 5 different STs, followed by MS7 (8 STs) and MS4 
(12 STs); MS1 was the most polymorphic, with 16 differ-
ent STs (Appendix Table). Combination of ITS with MS 
markers for the 22 complete isolates (isolates for which 
all MS markers were successfully sequenced) resulted in 
20 different MLGs (Appendix Table). Network analysis 
confirmed that the 3 isolates from the cluster cases in the 
hematology unit were very similar (Figure 3). M01-06 and 
M01-07 were 100% identical among the 1,904 nt positions 
analyzed. M01-05 differed slightly from MS7 at 1 tandem 
repeat. Overall, phylogenetic analyses confirmed the close 
relationship among the 3 isolates (Appendix Figure 4).
The MLG results, together with the short period be-
tween the occurrence of the 3 cluster cases and the associa-
tion of the new C-like01 genotype with the cluster cases, 
provided evidence that the isolates were epidemiologically 
related. In addition, the MLG analyses showed a high het-
erogeneity among isolates belonging to the same ITS geno-
type. Only M01-06/M01-07 (C-like01 ITS genotype) from 
cluster cases and M01-67/M01-68 (C-like04 ITS genotype) 
were 100% identical to each other. M01-67 and M01-68 
were isolated from 2 patients in center 1 during a 7-day 
period in 2017. M01-67 was isolated from a 61-year-old 
woman admitted to the department of internal medicine 
with rheumatoid purpura, and M01-68 was isolated from 
a 70-year-old woman with hepatocellular carcinoma who 
died after a hospital stay of 15 days in the hepatology de-
partment. The C-like04 genotype had also been identified 
2 years previously in a patient (M01-72) from center 1. 
However, this isolate was clearly different from the others 
(Figure 3).
Discussion
The infection rate of intestinal microsporidiosis remains 
elevated in children in developing countries (1). The inci-
dence among the HIV-positive population has been greatly 
reduced as a result of highly active antiretroviral tritherapy 
Figure 2. Hospitalization mapping for 3 patients with concomitant Enterocytozoon bieneusi microsporidiosis in the hematology unit of 
Center 1 university hospital, France. On the x-axis, dates (month-year) range from 5 months before to 5 months after the outbreak; on 
the y-axis, anonymous patient codes are given. The vertical arrow indicates the period December 26–28, 2017, when 2 patients, M01-05 
and M01-07, were concomitantly housed in the same clinical department (FH in the hematology unit). DH, day hospitalization; FH, full 
hospitalization; HICU, hematology intensive care unit; WH, week hospitalization.
Figure 3. Median-joining analysis of the multilocus sequence 
typing (MLST) data for 22 Enterocytozoon bieneusi isolates 
from 3 different hospital centers in France, determined by 
using Network version 5.0.1.1 and Network Publisher version 
2.1.1.2 software (http://www.fluxus-engineering.com). Circles 
are proportional to the frequency of each genotype (a total of 20 
multilocus genotypes were obtained based on segregating sites). 
Pairwise differences >25 single-nucleotide polymorphisms (SNPs) 
are shown close to branches, which were shortened for better 
presentation. Gray shading indicates isolates from the cluster 
investigated in this study. ITS, internal transcribed spacer.
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and subsequent immunity restoration (1). In addition to 
sporadic cases in travelers, infections in new populations 
of immunocompromised patients exposed to the disease 
are now emerging; these populations include solid-organ 
transplant recipients and patients who have cancer and he-
matologic malignancies. In our study, 1 of 25 patients from 
center 1 was HIV positive, and 15 of 25 were solid-organ 
transplant recipients (20,25). A recent monocentric study 
in a hospital in France estimated the overall prevalence of 
microsporidia spores in fecal samples over a 2-year period 
at 1.1% (26).
To study the epidemiology of pathogens and specifi-
cally to address outbreaks (27), sequence typing has long 
been considered to be the standard for most infectious 
diseases (11–14). Many previous studies focused on E. 
bieneusi were restricted to an overall determination of its 
genotype and investigated only nucleotide sequences of the 
ITS rDNA region (28,29). In 2011, Feng et al. reported a 
MLST-based method for E. bieneusi genotyping (16). This 
powerful tool has been widely used in animals and humans 
to decipher genetic diversity within the E. bieneusi species 
(10). We applied this method to an outbreak investigation. 
The MLST method generated a great length of microspo-
ridian DNA containing highly variable regions ranging 
from 1,856 to 2,160 bp. Thus, the discriminatory power be-
tween E. bieneusi strains was much stronger by this tech-
nique than with ITS genotyping alone.
Using the MLST genotyping method, we defined the 
E. bieneusi strains isolated from the 3 patients admitted to 
the hematology unit as a new genotype (C-like01); these 
strains were closely clustered. This finding supported the 
conclusion that these patients shared the same strain, like-
ly from a common source of contamination that remains 
undetermined (18). In our study, hospitalization mapping 
of the patients’ movements supported the hypothesis of 
nosocomial acquisition. Because this was a retrospective 
investigation, we were unable to evaluate the safety of 
the food and beverages that were provided to the patients 
in the hospital during the weeks before the report of the 
outbreak (30).
Reports of community-acquired foodborne or water-
borne microsporidiosis outbreaks are rare. The recent liter-
ature includes the massive epidemic in Lyon, France, with 
an attack rate of 1.0% in HIV-positive patients each month 
during the summer of 1995 (31). At that time, molecular 
tools were not available to investigate the epidemiologic 
links between microsporidian strains. In 2009, a probable 
outbreak in a hotel in Sweden involving 135 persons with 
an attack rate of 30.0% was associated with cucumber con-
sumption (32). In that study, the authors stated that 6 E. 
bieneusi strains were identified as genotype C, but no de-
tailed genotyping was performed to investigate the genetic 
relationships among the isolates. The authors reported the 
incubation period of E. bieneusi infection in this outbreak 
ranged from 0 to 21 days.
In our study, 2 of the 3 cluster case patients were hos-
pitalized >15 days before their first symptoms, which is 
compatible with nosocomial acquisition. The remaining 
patient was admitted to the short-stay oncology unit for 2 
days when microsporidiosis occurred, but he also visited 
the hospital every month for regular medical consultations. 
We cannot exclude the possibility that the transmission of 
E. bieneusi involved asymptomatic persons, such as tran-
siently colonized nurses and doctors or other patients as 
direct person-to-person contacts (33). However, few stud-
ies have been able to provide molecular evidence that 
colonized persons can serve as direct infectious sources 
(3,12). Comprehensive demonstration of transmission is 
hampered (34) because the time lapse for spore excretion 
in the feces and the minimal infective inoculum are un-
known. Indirect transmission is also a possibility because 
the spores have protective walls formed of proteins and 
chitin that would allow them to persist in the environment 
for at least several weeks (3).
With respect to these findings, it is difficult to define a 
robust method to prevent E. bieneusi infection in patients at 
risk. Recent data support the inclusion of microsporidia on 
the National Institutes of Health/Centers for Disease Con-
trol and Prevention biodefense category B list of pathogens 
of concern for waterborne and foodborne transmission. 
Unfortunately, official guidelines are scarce, especially re-
garding persons with hematologic malignancies. In HIV-
positive patients with T-cell lymphocyte CD4+ count <200 
cells/µL, the Centers for Disease Control and Prevention 
strongly recommends reducing environmental exposure by 
avoiding untreated water sources (level of evidence: AIII) 
(35). Regardless of the context, we suggest that standard 
hygiene precautions be used, including decontamination of 
the hands with an alcohol-based rub. In addition, wearing 
personal protective equipment when in close contact with 
infected patients should be standard practice, as should 
thorough cleaning of environmental surfaces.
In conclusion, our study presents a report of 3 cluster 
cases of microsporidiosis in a hospital and provides strong 
epidemiologic and molecular evidence of a common source 
of contamination. We also demonstrate the high genetic di-
versity of Enterocytozoon bieneusi. Our findings suggest 
that the MLG approach will further extend our knowledge 
about the epidemiology of microsporidiosis and that inci-
dence of nosocomial contamination may be more common 
than previously recognized.
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